Alpha Cognition, Inc. (ACOG)
6.08
-0.10
(-1.62%)
USD |
NASDAQ |
Jun 03, 16:00
5.82
-0.26
(-4.28%)
Pre-Market: 08:43
Alpha Cognition EPS Diluted (Quarterly) : -0.3208 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Nurix Therapeutics, Inc. | -0.792 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Anika Therapeutics, Inc. | -0.3737 |
| Savara, Inc. | -0.1472 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -6.478M |
| Revenue (Quarterly) | 3.534M |
| Total Expenses (Quarterly) | 10.01M |
| Enterprise Value | 78.08M |
| Gross Profit Margin (Quarterly) | 91.47% |
| Profit Margin (Quarterly) | -183.3% |
| Earnings Yield | -22.57% |
| Normalized Earnings Yield | -22.30 |